ISSN 2412-4036 (print)
ISSN 2713-1823 (online)

Urinary tract infections in patients of a psychosomatic department: Clinical and demographic features, risk factors, the role of psychopharmacotherapy, and treatment approaches

A.A. Anderzhanova, S.S. Lebedev, D.P. Kotova, M.V. Zhuravleva, S.V. Kotov, Yu.A. Melyoshkina, M.V. Lukina, M.A. Balalaeva

1) N.I. Pirogov City Clinical Hospital No. 1, Moscow, Russian Federation; 2) Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation; 3) I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation; 4) Scientific Centre for Expert Evaluation of Medicinal Products, Moscow, Russian Federation; 5) N.I. Pirogov Russian National Research Medical University (Pirogov University), Moscow, Russian Federation; 6) B.V. Petrovsky National Research Centre of Surgery, Moscow, Russian Federation; 7) N.N. Burdenko Main Military Clinical Hospital, Moscow, Russian Federation
Introduction. Urinary tract infections (UTIs) are among the most common infectious complications in hospitals. In patients with mental disorders, the risk of UTIs is increased due to advanced age, organic lesions of the central nervous system, urodynamic disorders, and the use of psychotropic drugs with anticholinergic activity. Objective: To study the incidence, clinical and demographic features, risk factors, the role of psychopharmacotherapy, and treatment approaches for UTIs in patients of a psychosomatic department of a multidisciplinary hospital. Material and methods. A retrospective single-center study based on the KLIOPS database. The analysis included data from 939 patients admitted to the psychosomatic department of N.I. Pirogov City Clinical Hospital No. 1 (Moscow). The diagnosis of UTI was verified in accordance with the clinical recommendations of the Russian Society of Urology. Results. UTIs were diagnosed in 80 (8.5%) patients; 67.5% of cases were nosocomial. Patients with UTIs were older (75.0 [67.0; 84.0] years vs. 64.0 [46.0; 79.0] years; p <0.001), more often had organic mental disorders (55.0% vs. 26.3%; p <0.001), and had higher Waterloo scores (12.0 [10.0; 14.0] vs. 9.0 [5.0; 14.0]; p <0.001). The most significant UTI risk factors were nephrolithiasis (OR 28.57), acute urinary retention (OR 5.72), neurogenic bladder (OR 5.28), and chronic kidney disease (OR 3.84). Enterococcus spp. predominated in the pathogen structure (41.7%). Overall, psychopharmacotherapy intake did not differ between groups (38.6% vs. 38.8%; p = 0.986). In the analysis by UTI, a significant difference was found only for amantadine (13.8% vs. 11.4%; p = 0.027). Acute urinary retention was significantly associated with clomipramine, amantadine, biperiden, quetiapine, and chlorprothixene (p <0.05). Conclusion. Patients of a psychosomatic department are at high risk of UTIs. The most significant risk factors are urodynamic disorders, chronic kidney disease, cerebrovascular pathology, and diabetes mellitus. Prescription of drugs with anticholinergic activity in patients with urodynamic disorders requires caution and monitoring of urinary function.

Keywords

urinary tract infections
psychosomatic department
psychopharmacotherapy
acute urinary retention
neurogenic bladder
anticholinergic burden
nosocomial infections

References

  1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–208.

    PMID: 24670166. PMCID: PMC4648343. https://doi.org/10.1056/NEJMoa1306801. Erratum in: N Engl J Med. 2022;386(24):2348. https://doi.org/10.1056/NEJMx210023

  2. Rodriguez-Salas FB, Merchan-Cruz MA, Ocana-Riola R, Diez-de-Baldeon-Chicon PM, Lara JP, Blanco-Reina E. Anticholinergic burden in community-dwelling older adults: Prevalence, associated factors, and agreement between measurement scales. Front Pharmacol. 2026;17:1886899.

    PMID: 42602028. PMCID: PMC13473269. https://doi.org/10.3389/fphar.2026.1886899

  3. Клинические рекомендации. Острый пиелонефрит. Российское общество урологов. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 9_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/9_3 (дата обращения – 15.09.2026). [Clinical guidelines. Acute pyelonephritis. Russian Society of Urologists. Rubricator of clinical guidelines of the Ministry of Healthcare Russia. 2024. ID: 9_3. URL: https://cr.minzdrav.gov.ru/view-cr/9_3 (date of access – 15.09.2026) (In Russ.)].
  4. Клинические рекомендации. Цистит у женщин. Российское общество урологов. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 14_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/14_3 (дата обращения – 15.09.2026). [Clinical guidelines. Cystitis in women. Russian Society of Urologists. Rubricator of clinical guidelines of the Ministry of Healthcare Russia. 2024. ID: 14_3. URL: https://cr.minzdrav.gov.ru/view-cr/14_3 (date of access – 15.09.2026) (In Russ.)].
  5. Drake MJ, Williams J, Bijos DA. Voiding dysfunction due to detrusor underactivity: An overview. Nat Rev Urol. 2014;11(8):454–64.

    PMID: 25002201. https://doi.org/10.1038/nrurol.2014.156

  6. Truzzi JC, de Almeida FG, Sacomani CA, Reis J, Rocha FET. Neurogenic bladder – concepts and treatment recommendations. Int Braz J Urol. 2022;48(2):220–43.

    PMID: 34156189. PMCID: PMC8932021. https://doi.org/10.1590/S1677-5538.IBJU.2021.0098

  7. Nazarko L. Acute urinary retention: Patient investigations and treatments. Br J Nurs. 2021;30(9):S4–S7.

    PMID: 33983809. https://doi.org/10.12968/bjon.2021.30.9.S4

  8. Ma X, Dong A, Liu K, Wu Y, Li L. Causal relationship between diabetes and urinary tract infections: A Mendelian randomization study. Medicine (Baltimore). 2026;105(28):e49673.

    PMID: 42432896. PMCID: PMC13362856. https://doi.org/10.1097/MD.0000000000049673

  9. Ishigami J, Grams ME, Chang AR, Carrero JJ, Coresh J, Matsushita K. CKD and risk for hospitalization with infection: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2017;69(6):752–61.

    PMID: 27884474. PMCID: PMC5438909. https://doi.org/10.1053/j.ajkd.2016.09.018

  10. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019;142(1):44–50.

    PMID: 30970355. https://doi.org/10.1159/000496492

  11. Stewart C, Yrjana K, Kishor M, Soiza RL, Taylor-Rowan M, Quinn TJ, et al. Anticholinergic burden measures predict older people’s physical function and quality of life: A systematic review. J Am Med Dir Assoc. 2021;22(1):56–64.

    PMID: 32709405. https://doi.org/10.1016/j.jamda.2020.05.065

  12. Tiranaprakij P, Srisuma S, Putthipokin K, Ruangritchankul S. Anticholinergic burden and clinical outcomes among older adults admitted in a tertiary hospital: A prospective cohort study. PLoS One. 2025;20(9):e0332946.

    PMID: 40971398. PMCID: PMC12448347. https://doi.org/10.1371/journal.pone.0332946

  13. Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA. 2016;316(17):1818–19.

    PMID: 27802529. https://doi.org/10.1001/jama.2016.16435

  14. Chapman GC, Sheyn D, Slopnick EA, Roberts K, El-Nashar SA, Henderson JW, et al. Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: A multicenter randomized controlled trial. Am J Obstet Gynecol. 2021;225(3):274.e1–274.e11.

    PMID: 33894146. https://doi.org/10.1016/j.ajog.2021.04.236

  15. Mansbart F, Kienberger G, Sonnichsen A, Mann E. Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: A systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr. 2022;22(1):771.

    PMID: 36171560. PMCID: PMC9516834. https://doi.org/10.1186/s12877-022-03415-7

About the Authors

Anastasia A. Anderzhanova, MD, PhD (Medicine), head of the Department of clinical pharmacology, N.I. Pirogov City Clinical Hospital No. 1, Moscow, Russian Federation.
E-mail: AnderzhanovaAA@zdrav.mos.ru
ORCID: https://orcid.org/0000-0001-7463-8603. Scopus ID: 58188991400. eLibrary SPIN: 8065-0980
Sergey S. Lebedev, MD, Dr. Sci. (Medicine), professor, chief physician of N.I. Pirogov City Clinical Hospital No. 1; associate professor of the Department of surgery, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation.
E-mail: lebedevssd@yandex.ru
ORCID: https://orcid.org/0000-0001-5366-1281. Scopus ID: 7103044979. eLibrary SPIN: 2736-0683
Daria P. Kotova, MD, Dr. Sci. (Med.), deputy chief physician for medical affairs, N.I. Pirogov City Clinical Hospital No. 1; professor of the Department of clinical pharmacology and therapy named after academician B.E. Votchal, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation.
E-mail: KotovaDP2@zdrav.mos.ru
ORCID: https://orcid.org/0000-0003-1071-0877. Scopus ID: 57201722524. eLibrary SPIN: 5690-4452
Marina V. Zhuravleva, MD, Dr. Sci. (Medicine), professor, chief external specialist in clinical pharmacology of the Department of Healthcare of Moscow; deputy director of Center for Clinical Pharmacology, Scientific Centre for Expert Evaluation of Medicinal Products, Moscow, Russian Federation.
E-mail: ZhuravlevaMV2@mos.ru
ORCID: https://orcid.org/0000-0002-9198-8661. Scopus ID: 55878917900. eLibrary SPIN: 6267-9901
Sergey V. Kotov, MD, Dr. Sci. (Medicine), professor, head of the Department of urology and andrology named after academician N.A. Lopatkin of the Institute of surgery, N.I. Pirogov Russian National Research Medical University (Pirogov University), Moscow, Russian Federation.
ORCID: https://orcid.org/0000-0003-3764-6131. Scopus ID: 57197653685. eLibrary SPIN: 4410-2226
Yulia A. Melyoshkina, MD, clinical pharmacologist of the Department of clinical pharmacology, N.I. Pirogov City Clinical Hospital No. 1, Moscow, Russian Federation.
E-mail: MeleshkinaYA@zdrav.mos.ru
ORCID: https://orcid.org/0000-0003-3768-6731. Scopus ID: 58188819400. eLibrary SPIN: 5088-6327
Maria V. Lukina, MD, PhD (Medicine), clinical pharmacologist of the Department of clinical pharmacology, N.I. Pirogov City Clinical Hospital No. 1; senior researcher at the Centralized department of clinical pharmacology, B.V. Petrovsky National Research Centre of Surgery, Moscow, Russian Federation.
E-mail: mari-luk2010@yandex.ru
ORCID: https://orcid.org/0000-0003-0032-2651. Scopus ID: 57090313500. eLibrary SPIN: 4570-6074
Maria A. Balalaeva, MD, PhD (Medicine), clinical pharmacologist of the Department of clinical pharmacology, N.I. Pirogov City Clinical Hospital No. 1; clinical pharmacologist at N.N. Burdenko Main Military Clinical Hospital, Moscow, Russian Federation.
E-mail: BalalaevaMA@zdrav.mos.ru
ORCID: https://orcid.org/0000-0001-5968-3297. Scopus ID: 57176306600. eLibrary SPIN: 9267-5440

Similar Articles